Chris Dowd

Access leaders are pressed to prove AI ROI, but ConnectiveRx execs Cindy Baksh and Steve Randall argue the real work is defining "better" first, then deciding where AI fits.

Chris Dowd and Lisa Prowker of ConnectiveRx discuss point-of-care marketing as the key activation layer for investments in patient access and support—it’s essential for converting dollars spent in payer negotiations and copay programs into prescriptions.

A four-pillar strategy to help ensure both, as copay programs face mounting payer pressure and misuse in 2026.

It’s not marketing—it's the activation layer for every dollar spent on patient access and support.

Amid intensified competition—and evolving IRA and PBM dynamics—leaders in the access space must now adopt a strategist mindset.

Conversation with chief tech expert explores AI’s rise in the support space—and separating the substance from the noise.

Doubling down on patient access and support fundamentals will win out over Washington’s next move.

The key strategies for reducing or eliminating post-prescription abandonment.

From matrix programs to anti-abandonment strategies, predictions for a new era.

What does the legislation mean for patient access leaders, pharma brand managers, and patient service owners? Industry experts weigh in.

The biggest areas of adjustment in patient support brought on by changes in consumer and physician behavior